Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Update of the MDS research criteria for prodromal Parkinson's disease

14 Aug 2019

Abstract excerpt

The MDS Research Criteria for Prodromal PD allow the diagnosis of prodromal Parkinson's disease using an evidence-based conceptual framework, which was designed to be updated as new evidence becomes available. New prospective evidence of predictive values of risk and prodromal markers published since 2015 was reviewed and integrated into the criteria. Many of the predictive values (likelihood ratios, LR) remain...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Neurological diseases and metabolism
Share to Parkinson's Disease Mechanisms and Treatments
Share to Voice and Speech Disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31412427
DOI: 10.1002/mds.27802

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Update of the MDS research criteria for prodromal Parkinson's diseasePMID 31412427Read ↗

Application of the Movement Disorder Society prodromal criteria in healthy G2019S-LRRK2 carriers.Semantic proximity Read ↗

Novel Variants Linked to the Prodromal Stage of Parkinson’s Disease (PD) PatientsSemantic proximity Read ↗

Parkinson DiseaseSemantic proximity Read ↗

Parkinson's disease.Semantic proximity Read ↗

Monogenic Parkinson's Disease: Genotype, Phenotype, Pathophysiology, and Genetic Testing.Semantic proximity Read ↗

Who is at Risk of Parkinson Disease? Refining the Preclinical Phase of GBA1 and LRRK2 Variant Carriers: a Clinical, Biochemical, and Imaging Approach.Semantic proximity Read ↗

Advances in Parkinson’s Disease: 200 Years LaterSemantic proximity Read ↗

The challenges with the identification of Parkinson's disease subtypes.Semantic proximity Read ↗

Pathogenesis of Parkinson’s disease: from hints from monogenic familial PD to biomarkersSemantic proximity Read ↗

Towards a Biological Definition of Parkinson’s DiseaseSemantic proximity Read ↗

199 years of Parkinson disease - what have we learned and what is the path to the future?Semantic proximity Read ↗

<i>RAB32</i>-linked Parkinson’s disease: Deep phenotyping, MDSGene literature review, and application of SynNeurGe criteriaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.